TT Electronics collaborating with iAbra for their prototype Virolens screening device

Drug testing lab

TT Electronics plc (LON:TTG) has noted the recent media coverage in relation to trials of Virolens®, a non-clinical COVID-19 screening device, at Heathrow airport.

TT has been working with iAbra, the creator of Virolens®, and its partners University of Bristol, Dell and Intel, to design, develop and test the prototype Virolens® screening device and to specify and design the manufacturing processes. 

TT Electronics has also been appointed exclusive manufacturing partner for the commercial launch of Virolens®. Revenues from Virolens® are dependent on iAbra’s end customers converting expressions of interest into firm orders, and subject to Virolens® meeting further regulatory authority requirements.

Find more news, interviews, share price & company profile here for:
TT Electronics plc

Good news travels fast (but only if you make that happen):

Share on twitter
Twitter
Share on linkedin
LinkedIn
Share on facebook
Facebook
Share on email
Email
Share on whatsapp
WhatsApp